I am a Rheumatology Specialist Registrar in South London and a Clinical Research Fellow at King's College London. My research focuses on the long-term safety of advanced immune therapies used to treat immune-mediated inflammatory diseases, with a particular emphasis on cancer risk.

My PhD, Cancer Risk and Advanced Immune Therapies in Immune-Mediated Inflammatory Diseases: Evidence Synthesis and Pharmacoepidemiological Approaches, uses Bayesian evidence synthesis, network meta-analysis, and pharmacoepidemiological methods to evaluate the comparative safety of biologic and targeted therapies. The aim is to generate evidence that informs clinical practice and improves patient care.

Alongside my research, I work clinically in rheumatology and as a sub-investigator on commercial and investigator-led clinical trials.